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Trachoma is an ancient blinding eye disease. With improvements in hygiene and living conditions and
development of targeted strategies by the World Health Organization, trachoma is being progressively
eliminated. Great progress is being seen in Asian countries, many of which are becoming trachoma free.
Copyright © 2016, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Trachoma is the blinding infection caused by Chlamydia tra-
chomatis.1 C. trachomatis is a Gram-negative bacteria that ﬁrst
evolved at the time of the dinosaurs.2 Basically, every vertebrate
species has evolved around its own particular species of Chla-
mydia.3 The human strains separated into a predominantly ocular
strain and general strains some 2e5 million years ago at about the
timewhen early human ancestors were evolving; however, modern
humans evolved only some 100,000 years ago.
Given this extraordinary history of coevolution, infection with
Chlamydia does not seem to have presented a major problem with
the evolution and health of early mankind. However, with the
development of early settlements and the start of agriculture at the
end of the past Ice Age some 12,000 years ago, things changed.
References to trachoma in China date back to the 27th century BC
when Emperor Huang Ti Nei Ching underwent surgery for trichi-
asis.4 Some of the earliest written records of trachoma are found in
bone writing from the Chang Dynasty (16the11th century BC).
Trachoma became a common and important condition in the
Yangtze and Yellow River Valleys in China. Similarly, trachoma also
appeared in the small farming communities developing in the
Euphrates Valley in Mesopotamia, along the Nile Valley in Egypt,
and along the Indus and Ganges Rivers in South Asia.1 As people
started to live in settlements, with increased crowding and poornterest to declare.
alth, The University of Mel-
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iety of Taiwan. Published by Elsevihygiene, chances of individuals repeatedly being infected with
Chlamydia increased, leading to the development of trachoma. A
single episode of chlamydial eye infection will usually resolve
without serious sequelae, but repeated episodes of reinfection lead
to blinding trachoma.
Clinically signiﬁcant outbreaks of chlamydial infection are also
seen in a variety of other animal species, particularly when they are
crowded together.5 When birds are crowded together, they develop
psittacosis; when cows, pigs, or sheep are crowded, they develop
problems such as chlamydial abortions. Even koalas and crocodiles,
when overcrowded, develop symptomatic chlamydial infections.62. Pathogenesis
The key to understanding the pathogenesis of trachoma is that
frequent and repeated episodes of reinfection are needed for the
development of severe disease.7,8 Repeated episodes of infection
induce a marked and sustained inﬂammatory response that, with
time, leads to scarring and structural damage.1 The changes in
trachoma are an immune response to the chlamydial antigens
released, as the Chlamydia organisms divide in the conjunctival
epithelial cells.9 In the eye, of course, this is characterized by the
characteristic inﬂammation, with follicles in the upper tarsal con-
junctiva lid, and scarring later. The more severe the inﬂammation
and the longer it persists, the more severe the scarring. With time,
the scars will contract to turn in the eye lashes, causing trichiasis,
corneal scarring, and blindness.
The key to preventing trachoma is to prevent the repeated epi-
sodes of reinfection by preventing transmission. Trachoma iser Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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infected ocular and nasal secretions. This usually occurs by direct
contact with ﬁngers, while children play or sleep together, or by the
use of shared towels or othermaterials used to clean children's faces.3. The 19th and 29th centuries
Although trachoma persisted in many areas over the past
2000 years, it was really 200 years ago after the Napoleonic Wars,
particularly during the ﬁghting in Egypt, that trachomawas seen as
a major health problem and also a military problem in Europe.1
Although trachoma seems to have existed in many cities, it was
not until a large number of soldiers became incapable of ﬁghting
because of their ocular infections that the authorities really took
notice of it. This coincided with the start of the Industrial Revolu-
tion in Europe, a time when a large number of people moved from
the countryside and crowded into slums and tenements on the
outskirts of newly developing industrial towns. Trachoma became a
major problem in the civilian population too.
The ﬁrst International Congress of Ophthalmology was held in
1857, and one of the two key agenda items was what to do about
trachoma.10 From the military perspective, trachoma could be
curtailed by having soldiers wash separately using clean water and
not sharing towels.11 In the 1890s, the United States established a
quarantine service for incoming emigrants from Central and
Eastern Europe who were examined and sent back if they were
found to have trachoma.12
For the general population, there was little advancement in the
treatment of trachoma other than cauterization of the inﬂamed
conjunctiva with silver nitrate or copper sulfate, or at times
curetting of follicles. Many variations of lid surgery that dated back
to ancient times were used to correct trichiasis.1
Although trachoma becamewidespread around theworld in the
1920s, it started to disappear in most developed countries as living
conditions improved during the ﬁrst half of the 20th century.1 The
advent of sulfonamides in the 1930s and then the development of
tetracyclines in the 1940s sped up this process so that trachoma had
disappeared from most developed areas by the 1950s and 1960s.
Data collected in Japan track the disappearance of trachoma during
the 20th century (Figure 1).13 Similar ﬁndings came from Taiwan.14
It has still remained an ongoing problem in most of the lessFigure 1. Trachoma prevalence indeveloped areas despite many attempts by the World Health Or-
ganization (WHO) to combat it.154. Identiﬁcation of Chlamydia
Chlamydia was ﬁrst identiﬁed in conjunctival scrapings in
studies undertaken in Indonesia, which used a Giesma stain to
show the now characteristic intracytoplasmic inclusions.16 The
inability to culture Chlamydia led investigators to assume that it
was a virus; although it is still not possible to culture the organism,
a number of experimental studies were undertaken to conﬁrm its
infectious nature and understand some of its epidemiology.1
The organism that caused trachoma was not identiﬁed until
1957 following the ground breaking research of four Chinese
ophthalmologists and scientists, Drs T'ang, Chang, Huang, and
Wang,17 at Tongren Eye Hospital, Beijing, China. They were the ﬁrst
group in the world to be able to culture Chlamydia. They showed
that Chlamydia is a Gram-negative bacterium that can grow only
within the cytoplasm of cells and divide by binary ﬁssion. The
ability to culture Chlamydia led to an explosion in the research of
Chlamydia with the development of a variety of new and improved
tests to identify infection and efforts to develop a vaccine.15. Trachoma in the 21st century
In 1998, the World Health Assembly passed a resolution calling
for global elimination of blinding trachoma by the year 2020.18 It
called on all member states to work and make that commitment a
reality. The ﬁgures pulled together byWHO in 2003 suggested that
some 49 million children in the Asia Paciﬁc region had active
trachoma and that over 3.5 million adults had trichiasis.19
WHO advocated the use of the SAFE strategy to eliminate
blinding trachoma, which includes surgery for inturned lashes,
antibiotic treatment, promotion of facial cleanliness, and environ-
mental improvement.20,21 Many countries undertook mass drug
administration using an annual dose of azithromycin. Pﬁzer (New
York, NY, USA), themanufacturer of this drug, committed to provide
azithromycin free of charge for this work, and the distribution is
coordinated through the International Trachoma Initiative. So far,
Pﬁzer has donated over 500 million doses of azithromycin.22Japanese school children.13
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ment organizations meet each year under the auspices of WHO at
the Global Alliance to Eliminate Trachoma. Over the past decade,
remarkable progress has been made and trachoma has been elim-
inated from a number of African and Middle East countries.21
Striking progress has also been made in the Asia Paciﬁc region.
Most striking of all is the oral announcement of elimination of
trachoma from China that was made in September 2015 at the In-
ternational Agency for the Prevention Blindness meetings held in
Beijing. Great progress has also been made in Cambodia and Nepal
that seem to have eliminated trachoma, and Vietnam and Laos
where trachoma is now reported to be seen only in some small,
more remote areas in the northern part of each country.23 Data are
still awaited from India where much progress is thought to have
been made. Published reports of recent surveys are still awaited.
Although active trachoma has been reduced in, or has dis-
appeared from, most areas, trichiasis still continues to be a major
problem. The need to identify and provide trichiasis surgery to
older people, who had severe trachoma in their childhood and
progress to develop trichiasis, will continue for many years.24
However, active trachoma still remains a problem in some
countries in the Asia Paciﬁc region. It persists in Afghanistan,
Myanmar, Pakistan, Papua New Guinea, and the Paciﬁc Island
countries of Fiji, Kiribati, Solomon Islands, and Vanuatu. Of course,
trachoma has been a signiﬁcant problem in the Australian
Aboriginal population for many years, but signiﬁcant progress has
been made over the past few years.25 The prevalence of trachom-
atous inﬂammationdfollicular is now less than 5%, although some
Aboriginal communities still have higher levels of trachoma.
6. Summary
Trachoma is an ancient disease that occurs in areas of poor
personal and community hygiene, where frequent exchange of
infected eye secretions is facilitated. The global efforts to eliminate
trachoma together with the continuing improvement in living
conditions and housing have seen a rapid decline of trachoma in
many regions in the Asia Paciﬁc and around the world. With
continuing efforts on the remaining “hotspots,” we can feel conﬁ-
dent of eliminating trachoma as a blinding disease from the Asia
Paciﬁc region by the year 2020.
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